Stress and the Impact of Personalized Medicine

Charles F. Gillespie, Elisabeth B. Binder, Paul E. Holtzheimer and Charles B. Nemeroff

in Integrative Neuroscience and Personalized Medicine

Published in print December 2010 | ISBN: 9780195393804
Published online January 2011 | e-ISBN: 9780199863495 | DOI:
Stress and the Impact of Personalized Medicine

Show Summary Details


This report summarizes a number of the epigenetic influence on the development and treatment of anxiety and mood disorders. The focus taken here is on the impact of stress and stressors on the endocrine axis and their effects on the anxiety and mood disorders. There have been a number of interesting leads as to what the relevant important genetic components may be however none have been studied sufficiently to be used as Personalized Medicine markers for anxiety or depression.

Keywords: Anxiety; Depression; Stress; Stressors; Abuse; Neuroendocrine; ghypothalamic-pituitary-adrenal axis; SNPs; Genes; Brain Imaging

Chapter.  12081 words. 

Subjects: Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.